ANDREA MOSER: Open Payments
NPI 1558332981 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,073 in 165 payments from 28 companies in 2025. Trend: 2023 $2,257 · 2024 $2,286 · 2025 $3,073
Food & beverage: $3,073
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 15 | $267 |
| Dexcom, Inc. | 18 | $264 |
| Corcept Therapeutics | 13 | $247 |
| Abbott Laboratories | 6 | $247 |
| Novo Nordisk Inc | 13 | $202 |
| Sequel Med Tech, LLC | 10 | $183 |
| SANOFI-AVENTIS U.S. LLC | 8 | $179 |
| Tandem Diabetes Care, Inc. | 8 | $168 |
| Amgen Inc. | 11 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $154 |
Products named: Dexcom G6 Transmitter, Korlym, FREESTYLE LIBRE 3, TWIIST, TZIELD, t:slim X2 Insulin Pump with Control-IQ, Kerendia, ISTURISA.
Industry payments across OK — which companies pay providers there.
